J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Endpoints NewsGoHealth files for bankruptcy, as Medicare Advantage insurers pull back

AgilentHow Investors May Respond To Agilent Technologies (A) Expanding AI-Enabled Lab Solutions And Oncology Diagnostics - simplywall.st

BioPharma DiveTango data add to growing momentum for pancreatic cancer drugs

Thermo FisherThermo Fisher Scientific Introduces New Mass Spectrometry Platforms and AI Software - Clinical Lab Products

BioPharma DiveIncyte to buy blood disorder drug in possibly $2B deal

FierceBiotechClinical-stage cancer biotech Treeline sees path to public markets via reverse merger

FierceBiotechADA: Dexcom CGM shows benefit in non-insulin diabetes patients

BioPharma DiveJ&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for up to $1B

Endpoints NewsTreeline to go public via reverse merger with Standard BioTools

Roche MediaThis Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug - Barron's

BioPharma DiveADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option

FierceBiotechResmed snaps up Noctrix Health in $340M sleep tech deal